USE OF PREDICTIVE PROBABILITIES IN PHASE II AND PHASE III CLINICAL TRIALS (Q4244517): Difference between revisions
From MaRDI portal
Added link to MaRDI item. |
Set profile property. |
||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Revision as of 14:56, 5 March 2024
scientific article; zbMATH DE number 1292936
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | USE OF PREDICTIVE PROBABILITIES IN PHASE II AND PHASE III CLINICAL TRIALS |
scientific article; zbMATH DE number 1292936 |
Statements
USE OF PREDICTIVE PROBABILITIES IN PHASE II AND PHASE III CLINICAL TRIALS (English)
0 references
5 September 1999
0 references
interim analyses
0 references
therapeutic equivalence
0 references
beta-binomial distribution
0 references
